Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

Fatal gastrointestinal hemorrhage after a single dose of dabigatran.

Kernan L, Ito S, Shirazi F, Boesen K.

Clin Toxicol (Phila). 2012 Aug;50(7):571-3. doi: 10.3109/15563650.2012.705290. Epub 2012 Jul 17.

PMID:
22800505
2.

Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.

Wychowski MK, Kouides PA.

Ann Pharmacother. 2012 Apr;46(4):e10. doi: 10.1345/aph.1Q747. Epub 2012 Apr 10.

PMID:
22496474
3.

Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.

Dumkow LE, Voss JR, Peters M, Jennings DL.

Am J Health Syst Pharm. 2012 Oct 1;69(19):1646-50.

PMID:
22997117
4.

Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.

[No authors listed]

Prescrire Int. 2012 Feb;21(124):33-6. Review.

PMID:
22413715
5.

Hemorrhagic complications associated with dabigatran use.

Chen BC, Viny AD, Garlich FM, Basciano P, Howland MA, Smith SW, Hoffman RS, Nelson LS.

Clin Toxicol (Phila). 2012 Nov;50(9):854-7. doi: 10.3109/15563650.2012.721888. Epub 2012 Sep 12.

PMID:
22970730
6.

Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.

Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS, Winchester JF.

Am J Kidney Dis. 2013 Sep;62(3):591-4. doi: 10.1053/j.ajkd.2013.02.361. Epub 2013 Apr 16.

PMID:
23597859
7.

Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.

Béné J, Saïd W, Rannou M, Deheul S, Coupe P, Gautier S.

Ann Pharmacother. 2012 Jun;46(6):e14. doi: 10.1345/aph.1Q705. Epub 2012 Jun 5.

PMID:
22669799
8.

Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.

Ross B, Miller MA, Ditch K, Tran M.

J Med Toxicol. 2014 Jun;10(2):223-8. doi: 10.1007/s13181-013-0364-1.

9.

Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.

Fieland D, Taylor M.

Ann Pharmacother. 2012 Jan;46(1):e3. doi: 10.1345/aph.1Q474. Epub 2011 Dec 27.

PMID:
22202498
10.

Dabigatran in atrial fibrillation: pharmacology and clinical trials.

Ezekowitz MD, Nagarakanti R.

J Interv Card Electrophysiol. 2011 Dec;32(3):173-80. doi: 10.1007/s10840-011-9593-x. Epub 2011 Jun 30.

PMID:
21717198
11.

Clinical challenges in a patient with dabigatran-induced fatal hemorrhage.

Cano EL, Miyares MA.

Am J Geriatr Pharmacother. 2012 Apr;10(2):160-3. doi: 10.1016/j.amjopharm.2012.02.004. Epub 2012 Mar 3.

PMID:
22386824
12.

Probable interaction between warfarin and marijuana smoking.

Yamreudeewong W, Wong HK, Brausch LM, Pulley KR.

Ann Pharmacother. 2009 Jul;43(7):1347-53. doi: 10.1345/aph.1M064. Epub 2009 Jun 16.

PMID:
19531696
13.

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.

Circulation. 2011 May 31;123(21):2363-72. doi: 10.1161/CIRCULATIONAHA.110.004747. Epub 2011 May 16.

14.

Intravenous thrombolysis in a stroke patient taking dabigatran.

Lee VH, Conners JJ, Prabhakaran S.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):916.e11-2. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.008. Epub 2012 May 16.

PMID:
22608344
15.

The use of dabigatran immediately after atrial fibrillation ablation.

Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.

J Cardiovasc Electrophysiol. 2012 Mar;23(3):264-8. doi: 10.1111/j.1540-8167.2011.02175.x. Epub 2011 Sep 28.

PMID:
21955008
16.

Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification.

Clemens A, Haertter S, Friedman J, Brueckmann M, Stangier J, van Ryn J, Lehr T.

Curr Med Res Opin. 2012 Feb;28(2):195-201. doi: 10.1185/03007995.2011.654109. Epub 2012 Jan 23.

PMID:
22208675
17.

Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin?

Hughes PJ, Freeman MK.

Consult Pharm. 2012 Jun;27(6):445-52. doi: 10.4140/TCP.n.2012.445.

PMID:
22698551
18.

Potential inaccuracy of point-of-care INR in dabigatran-treated patients.

Baruch L, Sherman O.

Ann Pharmacother. 2011 Jul;45(7-8):e40. doi: 10.1345/aph.1Q105. Epub 2011 Jun 28.

PMID:
21712509
19.

Preventing cardioembolic stroke in atrial fibrillation with dabigatran.

Weimar C, Hohnloser SH, Eikelboom JW, Diener HC.

Curr Neurol Neurosci Rep. 2012 Feb;12(1):17-23. doi: 10.1007/s11910-011-0229-4. Review.

PMID:
21960064
20.

Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.

Bendel SD, Bona R, Baker WL.

Adv Ther. 2011 Jun;28(6):460-72. doi: 10.1007/s12325-011-0025-1. Epub 2011 Apr 26. Review.

PMID:
21533567

Supplemental Content

Support Center